ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,721.97
0.49%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. T2 Biosystems Inc (TTOO)

  7. T2 Biosystems Inc (TTOO) Noticias

TTOO T2 Biosystems Inc

2.81
0.07 (2.55%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
T2 Biosystems Inc TTOO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.07 2.55% 2.81 23:00:04
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.76 2.7001 2.9353 2.84 2.74
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202408:00GLOBET2 Biosystems to Report First Quarter 2024 Financial Results..
11/4/202415:05GLOBET2 Biosystems Shareholders Vote for CRG Debt Conversion into..
28/3/202408:00GLOBET2 Biosystems Announces Extension of Multi-Year Capital..
20/3/202406:30GLOBET2 Biosystems Unveils T2Lyme Launch Plans and Provides..
19/3/202408:00GLOBET2 Biosystems to Host Investor Call on March 20, 2024 to..
18/3/202408:00GLOBET2 Biosystems Announces New Publication Highlighting the..
12/3/202408:00GLOBET2 Biosystems Receives Extension to Comply with Nasdaq..
04/3/202415:34EDGAR2Form DEF 14A - Other definitive proxy statements
27/2/202415:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202416:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202416:00EDGAR2Form 8-K - Current report
15/2/202415:49EDGAR2Form PRE 14A - Other preliminary proxy statements
15/2/202415:47EDGAR2Form 8-K - Current report
15/2/202415:06GLOBET2 Biosystems Announces Preliminary Fourth Quarter and Full..
15/2/202415:04GLOBET2 Biosystems Announces Agreement with CRG for the..
15/2/202415:02GLOBET2 Biosystems Announces Commercial Expansion Through..
13/2/202419:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202408:00GLOBET2 Biosystems Receives FDA 510(k) Clearance for the Expanded..
07/2/202415:05GLOBET2 Biosystems to Report Fourth Quarter and Full Year 2023..
18/1/202408:00GLOBET2 Biosystems Announces Participation in NIH-funded..
05/1/202415:00EDGAR2Form 8-K - Current report
03/1/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202408:00GLOBET2 Biosystems Announces FDA 510(k) Submission to Expand Use..
28/11/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202315:00EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
24/11/202315:30EDGAR2Form 8-K/A - Current report: [Amend]
03/11/202308:00GLOBET2 Biosystems to Participate in the Canaccord Genuity..
01/11/202308:08EDGAR2Form 8-K - Current report
01/11/202308:00GLOBET2 Biosystems Regains Compliance with Nasdaq Listing..
25/10/202308:02EDGAR2Form 8-K - Current report
24/10/202315:05GLOBET2 Biosystems Highlights New Clinical Data Presented at..
23/10/202308:00EDGAR2Form 8-K - Current report
23/10/202308:00GLOBET2 Biosystems Announces Amendment and Extension of CRG Term..
20/10/202315:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202315:31EDGAR2Form 8-K - Current report
12/10/202315:32EDGAR2Form 8-K - Current report
12/10/202315:05GLOBET2 Biosystems Announces Preliminary Third Quarter 2023..
12/10/202315:02GLOBET2 Biosystems Announces FDA 510(k) Submission to Expand the..
12/10/202315:01EDGAR2Form 8-K - Current report
12/10/202308:00GLOBET2 Biosystems Announces Reverse Stock Split Effective Today
11/10/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
TTOO
T2 Biosystems
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados